MSc in Cancer and Therapeutics
offered by QMUL

Public University
5 Campuses
Estd. 1887

MSc in Cancer and Therapeutics
at
QMUL
Overview

You’ll study and contribute to the latest developments in curing cancer, such as novel drugs and gene therapy

Duration	24 months
Start from	Start Now
Total fee	₹30.46 Lakh
Mode of learning	Online
Official Website	Go to Website
Course Level	PG Degree

MSc in Cancer and Therapeutics
at
QMUL
Highlights

Earn a degree from Queen Mary University of London
Learn from industry experts
Scholarship facility available

MSc in Cancer and Therapeutics
at
QMUL
Course details

Skills you will learn

Statistics Communication skills

Who should do this course?

Biomedical Scientists
Pharmaceutical Scientists
Medical Doctors (MDs) and Oncologists

What are the course deliverables?

Explore the different types of cancer and their unique therapeutic vulnerabilities
Understand the clinical presentation, diagnosis, and management of different cancers
Develop effective communication skills to interact with patients, families, and healthcare professionals
Develop expertise in bioinformatic tools and statistical analysis methods for interpreting complex cancer data
Learn to critically evaluate scientific literature and stay updated on the latest advancements in cancer research

More about this course

This programme gives you a thorough grounding in the scientific principles underlying cancer treatment
In this course students will discover how new treatments are developed, evaluated and implemented
Students will also be equipped with a thorough knowledge of cancer biology and pathology, research methodologies, drug development, and regulatory issues

MSc in Cancer and Therapeutics
at
QMUL
Curriculum

Cancer Biology

Cancer Pharmacology

Drug Development

Cancer Prevention and Screening

Molecular Diagnostics and Therapeutics

Molecular Targeted Therapies and Immunotherapy for Blood Cancers

Dissertation

Research Methods

Clinical Cancer Treatment (CCT)

MSc in Cancer and Therapeutics
at
QMUL
Faculty details

Professor John F. Marshall

I study the biology of tumour invasion with a particular interest in the roles of the adhesion molecules expressed on the cell surface that mediate this process. Our group concentrates on the study of integrins that are the principal family of adhesion molecules that mediate interaction between cells and the extracellular matrix (ECM).